fig1

Endothelial dysfunction as a driver of microvascular injury in diabetic cardiomyopathy

Figure 1. Pathogenesis of DCM. Prolonged hyperglycemia leads to metabolic changes in the myocardium, which converge on ED. This impairs normal endothelial function, manifesting as increased EC loss, increased transformation of ECs into fibroblasts (through EndoMT), elevated vascular permeability with immune cell infiltration into the myocardium, impaired vasodilation, and defective angiogenesis[3,4,7,10]. Excessive fibroblast transition and heightened inflammatory signaling drive progressive myocardial fibrosis, reducing ventricular relaxation and leading to diastolic dysfunction. Meanwhile, impaired endothelial vasodilation and angiogenesis causes vascular stiffening and rarefaction, reducing myocardial perfusion. The resulting nutrient and oxygen deficiency in energy-demanding CMs triggers apoptosis, eventually impairing systolic function. Over time, combined systolic and diastolic dysfunction culminates in heart failure, as observed in the late stages of DCM[2]. DCM: Diabetic cardiomyopathy; ED: endothelial dysfunction; EC: endothelial cell; EndoMT: endothelial-to-mesenchymal transition; CM: cardiomyocyte; PKC: protein kinase C; ULK: Unc-51-like autophagy activating kinase; vWF: von Willebrand factor; PECAM1: platelet endothelial cell adhesion molecule-1; VE-CAD: vascular endothelial cadherin; α-SMA: α-smooth muscle actin; NO: nitric oxide; ET-1: endothelin-1; VEGF: vascular endothelial growth factor; IL: interleukin; TNF: tumor necrosis factor; VCAM: vascular cell adhesion molecule; ICAM: intercellular adhesion molecule; MCP: monocyte chemoattractant protein. [Created in BioRender. Justin R (2025)].

Vessel Plus
ISSN 2574-1209 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/